Upcoming Courses

Winter Seminar: Essential Psychopharmacology, 2014

Carl Salzman, MD

March 3, 2014 – December 6, 2013 | Naples, FL | The Naples Beach Hotel and Golf Resort More Information

An updated review of neurobiology and brain function will be presented. Specific categories of treatment will include treatment of schizophrenia, bipolar disorder, depression, anxiety, sleep disorders, borderline personality and eating disorders. The course will address strategies for bipolar patients who are noncompliant or treatment-resistant; approaches to the acutely psychotic, recovering psychotic patient, and the concept of early intervention. The role of medical switch versus augmentation strategies for treatment-resistant depression will be reviewed. Psychiatric medications for the elderly will be reviewed, including dosage adjustments for age, drug interactions, and sensitivity to side effects. The role of psychopharmacology in the treatment of obsessive symptoms, panic symptoms, and traumatic syndromes will be emphasized. The course will emphasize the establishment and importance of therapeutic alliance when prescribing all psychotropic medications, the interplay between pharmacologic and nonpharmacologic treatments, benefits and hazards of prescriber/non-prescriber co-treatment relationships. Educational presentation will be in seminar format and include lectures, participant discussion and Q & A.

This course is designed so that participants will be able to:
  • Evaluate psychotropic drug treatment options with particular emphasis on recent advances and practical prescribing information;
  • Analyze the latest research in neurobiology and brain function;
  • Implement treatment strategies for bipolar patients who are noncompliant or treatmentresistant;
  • Incorporate evidence-based approaches to treating acutely psychotic and recovering psychotic patient;
  • Determine when to implement medical switch versus augmentation strategies for treatmentresistant depression;
  • Make dosage adjustments in the elderly for age, drug interactions, and sensitivity to side effects;
  • Describe the role of psychopharmacology in the treatment of anxiety, sleeping disorders, obsessive symptoms, panic symptoms, and traumatic syndrome;
  • Determine pharmacologic approaches to the patient with personality disorder;
  • Develop a therapeutic alliance when prescribing psychotropic medications;
  • Describe the interplay between pharmacologic and non-pharmacologic treatments;
  • Review the benefits and hazards of prescriber/non-prescriber co-treatment relationships.

Additional Information

Monday, March 3, 2014: A simplified and clinically relevant review of neurobiology as it applies to clinical psychopharmacology; neurotransmission, synapses, second messengers; gene function and an introduction to gene/environment interaction and prevention; dual diagnosis.

Tuesday, March 4, 2014:


Biology and treatment of schizophrenia disorders: the new generation of antipsychotic drugs; clinical aspects of treatment: use of typical and atypical neuroleptics; concept of early intervention and prevention; dual diagnosis. treatment of bipolar disorders.


Wednesday, March 5, 2014:


Depression; Neurobiology of Depression; diagnostic heterogeneity; what constitutes response? value of tricyclics; SSRI’s in perspective; new antidepressants; combination and augmentation strategies; new approaches to the bipolar patient.


Thursday, March 6, 2014:


Anxiety, + panic, + OCD: Which drug, when to use; how much and for how long? rational benzodiazepine use; non-benzodiazepine strategies; use of hypnotics; PTSD; eating disorders.


Friday, March 7, 2014:


Diagnostic diversity and realistic pharmacologic treatment; geriatrics; personality disorders: is there a role for psychopharmacology?; dual diagnosis: alcohol/ substance abuse and psychiatric disorders; psychotherapeutic issues: dynamic, behavioral, supportive; psychodynamics of prescribing; diverse meaning of medications.

Beth Israel Deaconess Department of Psychiatry Foundation, Inc./Contact Hours: 15


The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Harvard Medical School designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Psychologists: The Massachusetts School of Professional Psychology (MSPP) is approved by the American Psychological Association to offer continuing education for psychologists. Massachusetts School of Professional Psychology maintains responsibility for this program and its content.

Counselors: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School is an NBCC-Approved Continuing Education Provider (ACEPTM) and may offer NBCC-approved clock hours for events that meet NBCC requirements. The ACEPTM solely is responsible for all aspects of the program.” The winter seminar programs meet the criteria for 15 clock hours.

Social Workers: Application for social work continuing education credits has been submitted.

Nurses: This activity has been submitted to the Ohio Nurses Association (OBN-001-91) for approval to award contact hours. The Ohio Nurses Association is accredited as an approver of continuing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Educators: Application has been made to Commonwealth of Massachusetts to offer Professional Development Points(PDP’s).

Please call Stacy Ruiz at 617-754-1265 or e-mail sjruiz@bidmc.harvard.edu for more information about your credit hours.

Carl Salzman, MD Professor of Psychiatry, Harvard Medical School. He has served as Chairman, American Psychiatric Association Benzodiazepine Task Force. He has been awarded the Elvin Semrad Award for Outstanding Teaching in Psychiatry at the Massachusetts Mental Health Center. He shared the Vestermark Award from the American Psychiatric Association for Outstanding Contribution to Psychiatric Education. He was awarded the Heinz E. Lehmann Award from the New York State Department of Mental Hygiene for his contribution to psychiatric research. In 2003 Dr. Salzman was nationally recognized with a Teacher of the Year Award. In 2006, he received the Outstanding Educator Award from the Massachusetts Psychiatric Society. He has also been on numerous editorial boards including The American Journal of Psychiatry. Dr. Salzman is the author of over 300 publications and 7 books. His latest book is Clinical Geriatric Psychopharmacology, 4th edition.